IDO1 was overexpressed in tumours from NSND vs SD (P = .0046). Elderly female patients were more common in NSND and harboured less gene mutations (P = .0006). PD‐L1 and IDO1 were co‐overexpressed, suggesting a higher potential benefit of combination therapy involving both. This evidence concerns the gene IDO1 and neoplasm.